The trademark MAJUNO was filed by BIOFARMA, a corporation established under the laws of the French Republic (the "Applicant"). The application was published for oppositions on February 4, 2021, and received one opposition filed on May 3, 2021 by Novartis AG on Likelihood of confusion. the opponent was represented by MIIP MADE IN IP and proceedings were handled in French, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued May 3, 2021
The application was filed in French, and French was also language of all opposition proceedings (English was selected as the second language).